Uniswap has already doubled from its bottom and is now consolidating strongly around $9.19, showing resilience as one of DeFi’s core engines.Uniswap has already doubled from its bottom and is now consolidating strongly around $9.19, showing resilience as one of DeFi’s core engines.

UNI Gears Up for Next Bull Run After Surging 100% to $9.19

2025/09/22 05:24
Okuma süresi: 3 dk
Bu içerikle ilgili geri bildirim veya endişeleriniz için lütfen [email protected] üzerinden bizimle iletişime geçin.
Whale Activity Signals Bull Run in Crypto Market

The rally has caught the attention of traders who are watching for a breakout toward the $12 range, with the asset building momentum on both technical and fundamental strength.

Conviction Pays Off for Early UNI Buyers

In a recent X post, analyst X Finance Bull highlighted how conviction and data-driven analysis led to catching the bottom in Uniswap’s price action. The analyst noted that buying at the lows has already returned over 100%, proving once again that DeFi’s real strength lies in execution rather than theory. The crypto, as a core engine of decentralized finance, has demonstrated resilience through market volatility.

Conviction Pays Off for Early UNI Buyers

Source: X

The first chart shows the token bouncing sharply off its lows and holding a strong consolidation range between $7 and $13. That 153% rally from the bottom suggests significant demand buildup and renewed investor confidence in the memecoin’s role in powering DeFi infrastructure. X Finance Bull emphasizes this as not hype but a simple observation of liquidity and volume flows.

For traders and long-term holders, this bottom call reinforces the value of disciplined conviction in the market. By identifying accumulation zones and sticking to fundamentals, the coin rebound demonstrates how smart positioning can generate outsized returns when the broader sector regains traction.

Data Supports Long-Term Potential

In supporting the analyst’s views, fresh data from BraveNewCoin provides strong fundamentals. Uniswap currently trades at $9.19 with a market cap of $5.51 billion, ranking #38 among crypto assets. Daily trading volume sits at $170M+, reflecting ongoing market participation and liquidity despite price consolidation.

Data Supports Long-Term Potential

Source: BraveNewCoin

The supply dynamics are also clear — 600 million tokens are in circulation, ensuring transparent tokenomics. Unlike speculative projects, the token backs these figures with proven on-chain activity, processing billions in volume across DeFi markets. These hard numbers reinforce the notion that the asset is not just a narrative play but an operational backbone in decentralized finance.

Technicals Signal a Cooling Period

At the time of writing, the coin was trading at $9.19 according to TradingView data. Recent price action shows UNI pulling back from highs near $12.30, with support forming around the $9 level. MACD readings (-0.030) indicate a slight bearish crossover, while the histogram remains close to neutral, suggesting reduced momentum.

Technicals Signal a Cooling Period

Source: TradingView

The Relative Vigor Index (RVI) also hovers around 50.4, signaling indecision as bulls and bears battle for short-term control. Price remains above the key low of $4.55, maintaining a strong higher-low structure that keeps the broader uptrend intact. Consolidation around current levels may serve as a healthy reset before another push higher.

If the asset holds above $9, it could provide a launchpad for a retest of resistance in the $11–$12 range. Conversely, a breakdown below this level may invite further correction toward $7.50, where strong buying previously emerged. Overall, the technicals suggest the crypto is in a cooling period, building the base for its next significant move.

Piyasa Fırsatı
DeFi Logosu
DeFi Fiyatı(DEFI)
$0.000325
$0.000325$0.000325
0.00%
USD
DeFi (DEFI) Canlı Fiyat Grafiği
Sorumluluk Reddi: Bu sitede yeniden yayınlanan makaleler, halka açık platformlardan alınmıştır ve yalnızca bilgilendirme amaçlıdır. MEXC'nin görüşlerini yansıtmayabilir. Tüm hakları telif sahiplerine aittir. Herhangi bir içeriğin üçüncü taraf haklarını ihlal ettiğini düşünüyorsanız, kaldırılması için lütfen [email protected] ile iletişime geçin. MEXC, içeriğin doğruluğu, eksiksizliği veya güncelliği konusunda hiçbir garanti vermez ve sağlanan bilgilere dayalı olarak alınan herhangi bir eylemden sorumlu değildir. İçerik, finansal, yasal veya diğer profesyonel tavsiye niteliğinde değildir ve MEXC tarafından bir tavsiye veya onay olarak değerlendirilmemelidir.

Ayrıca Şunları da Beğenebilirsiniz

Michael Saylor Pushes Digital Capital Narrative At Bitcoin Treasuries Unconference

Michael Saylor Pushes Digital Capital Narrative At Bitcoin Treasuries Unconference

The post Michael Saylor Pushes Digital Capital Narrative At Bitcoin Treasuries Unconference appeared on BitcoinEthereumNews.com. The suitcoiners are in town.  From a low-key, circular podium in the middle of a lavish New York City event hall, Strategy executive chairman Michael Saylor took the mic and opened the Bitcoin Treasuries Unconference event. He joked awkwardly about the orange ties, dresses, caps and other merch to the (mostly male) audience of who’s-who in the bitcoin treasury company world.  Once he got onto the regular beat, it was much of the same: calm and relaxed, speaking freely and with confidence, his keynote was heavy on the metaphors and larger historical stories. Treasury companies are like Rockefeller’s Standard Oil in its early years, Michael Saylor said: We’ve just discovered crude oil and now we’re making sense of the myriad ways in which we can use it — the automobile revolution and jet fuel is still well ahead of us.  Established, trillion-dollar companies not using AI because of “security concerns” make them slow and stupid — just like companies and individuals rejecting digital assets now make them poor and weak.  “I’d like to think that we understood our business five years ago; we didn’t.”  We went from a defensive investment into bitcoin, Saylor said, to opportunistic, to strategic, and finally transformational; “only then did we realize that we were different.” Michael Saylor: You Come Into My Financial History House?! Jokes aside, Michael Saylor is very welcome to the warm waters of our financial past. He acquitted himself honorably by invoking the British Consol — though mispronouncing it, and misdating it to the 1780s; Pelham’s consolidation of debts happened in the 1750s and perpetual government debt existed well before then — and comparing it to the gold standard and the future of bitcoin. He’s right that Strategy’s STRC product in many ways imitates the consols; irredeemable, perpetual debt, issued at par, with…
Paylaş
BitcoinEthereumNews2025/09/18 02:12
Trump White House Registers Aliens.gov—Is the UFO File Drop Imminent?

Trump White House Registers Aliens.gov—Is the UFO File Drop Imminent?

The post Trump White House Registers Aliens.gov—Is the UFO File Drop Imminent? appeared on BitcoinEthereumNews.com. In brief The White House registered aliens.gov
Paylaş
BitcoinEthereumNews2026/03/19 05:33
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Paylaş
BitcoinEthereumNews2025/09/18 05:26